Debora Santos Bruno, MD | |
815 N Kansas Ave, Suite 100, Hastings, NE 68901-4470 | |
(402) 460-5899 | |
(402) 460-5619 |
Full Name | Debora Santos Bruno |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 27 Years |
Location | 815 N Kansas Ave, Hastings, Nebraska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437100302 | NPI | - | NPPES |
249581 | Other | NE | MIDLANDS CHOICE |
30418 | Other | NE | BLUE CROSS BLUE SHIELD |
200385920A | Medicaid | KS | |
10025662600 | Medicaid | NE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 23664 (Nebraska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Hospitals Of Cleveland | Cleveland, OH | Hospital |
Parma Community General Hospital | Parma, OH | Hospital |
University Hospitals Portage Medical Center | Ravenna, OH | Hospital |
University Hospitals Ahuja Medical Center | Beachwood, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Hospitals Medical Group Inc | 4789682493 | 1466 |
News Archive
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the use of medications to treat high blood pressure affect outcomes among patients who are prescribed the medication and hospitalized with COVID-19.
Researchers at the UC Davis M.I.N.D. Institute have found that infants later diagnosed with autism exhibited unusual exploration of objects long before being diagnosed.
Diamyd Medical announces today that one hundred study participants have been included in the ongoing US Phase III study, DiaPrevent. The global Phase III program with the company's lead drug candidate Diamyd® has thereby enrolled more than 430 children newly diagnosed with type 1 diabetes in Europe and the USA.
A new report by AARP Pennsylvania and Drexel University's College of Nursing and Health Professions highlights how geographic, racial/ethnic and economic factors are combining to restrict access to health care services for many Pennsylvanians, creating disparities that have become more pronounced during the COVID-19 pandemic.
› Verified 3 days ago
Entity Name | The Metrohealth System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053353896 PECOS PAC ID: 8628982949 Enrollment ID: O20031119000355 |
News Archive
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the use of medications to treat high blood pressure affect outcomes among patients who are prescribed the medication and hospitalized with COVID-19.
Researchers at the UC Davis M.I.N.D. Institute have found that infants later diagnosed with autism exhibited unusual exploration of objects long before being diagnosed.
Diamyd Medical announces today that one hundred study participants have been included in the ongoing US Phase III study, DiaPrevent. The global Phase III program with the company's lead drug candidate Diamyd® has thereby enrolled more than 430 children newly diagnosed with type 1 diabetes in Europe and the USA.
A new report by AARP Pennsylvania and Drexel University's College of Nursing and Health Professions highlights how geographic, racial/ethnic and economic factors are combining to restrict access to health care services for many Pennsylvanians, creating disparities that have become more pronounced during the COVID-19 pandemic.
› Verified 3 days ago
Entity Name | University Hospitals Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the use of medications to treat high blood pressure affect outcomes among patients who are prescribed the medication and hospitalized with COVID-19.
Researchers at the UC Davis M.I.N.D. Institute have found that infants later diagnosed with autism exhibited unusual exploration of objects long before being diagnosed.
Diamyd Medical announces today that one hundred study participants have been included in the ongoing US Phase III study, DiaPrevent. The global Phase III program with the company's lead drug candidate Diamyd® has thereby enrolled more than 430 children newly diagnosed with type 1 diabetes in Europe and the USA.
A new report by AARP Pennsylvania and Drexel University's College of Nursing and Health Professions highlights how geographic, racial/ethnic and economic factors are combining to restrict access to health care services for many Pennsylvanians, creating disparities that have become more pronounced during the COVID-19 pandemic.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Debora Santos Bruno, MD 702 W 35th St, Hastings, NE 68901-7385 Ph: (402) 460-5899 | Debora Santos Bruno, MD 815 N Kansas Ave, Suite 100, Hastings, NE 68901-4470 Ph: (402) 460-5899 |
News Archive
A new trial led by the Perelman School of Medicine at the University of Pennsylvania will evaluate whether the use of medications to treat high blood pressure affect outcomes among patients who are prescribed the medication and hospitalized with COVID-19.
Researchers at the UC Davis M.I.N.D. Institute have found that infants later diagnosed with autism exhibited unusual exploration of objects long before being diagnosed.
Diamyd Medical announces today that one hundred study participants have been included in the ongoing US Phase III study, DiaPrevent. The global Phase III program with the company's lead drug candidate Diamyd® has thereby enrolled more than 430 children newly diagnosed with type 1 diabetes in Europe and the USA.
A new report by AARP Pennsylvania and Drexel University's College of Nursing and Health Professions highlights how geographic, racial/ethnic and economic factors are combining to restrict access to health care services for many Pennsylvanians, creating disparities that have become more pronounced during the COVID-19 pandemic.
› Verified 3 days ago
Richard French, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2115 N Kansas Ave, Ste 105a, Hastings, NE 68901 Phone: 402-463-2454 Fax: 402-463-2450 | |
Donald R. Snodgrass, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 223 E 14th St, Ste 100, Hastings, NE 68901 Phone: 402-463-2929 | |
James Hervert Jr., MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2115 N Kansas Ave, Hastings, NE 68901 Phone: 402-463-2454 Fax: 402-463-2450 | |
Dr. Shanon Dail Smith, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 715 N Saint Joseph Ave, Hastings Radiology Associates, Hastings, NE 68901 Phone: 402-461-5191 | |
Dr. Ramez J Habash, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 715 N Kansas Ave, # 202, Hastings, NE 68901 Phone: 402-463-2344 Fax: 402-463-2355 | |
Abhijeet Basoor, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 715 North Kansas, Ste 100, Hastings, NE 68901 Phone: 402-460-5555 Fax: 402-460-5593 | |
Daniel B Einspahr, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 715 N Saint Joseph Ave, Hastings, NE 68901 Phone: 402-463-4521 Fax: 402-347-4952 |